JIVI®

Jivi®

FDA INDICATION: For use in previously treated adults and adolescents (12 years of age and older) with hemophilia A (congenital Factor VIII deficiency) for on-demand treatment and control of bleeding episodes, perioperative management of bleeding, and routine prophylaxis to reduce the frequency of bleeding episodes. Package Insert

CLASS: Recombinant, PEGylated-aucl

DISTRIBUTOR: Bayer

ASSAY SIZE (IU): 500, 1000, 2000, 3000

DILUENT SIZE: 2.5 mL (pre-filled syringe)

MIXING DEVICE: Vial adapter

ROOM TEMPERATURE STORAGE: Up to 6 months at a temperature not to exceed 77°F

HALF-LIFE: 17.9 ± 4.0 hours

OTHER WEBSITES: livingwithhemophilia.com, pharma.bayer.comjivi.com